5E3 (Aptevo Therapeutics)

N/A

Report date: 2025/01/26 18:50:27

Base Information

Drug Name5E3 (Aptevo Therapeutics)
Drug Alias Name5E3 (Emergent BioSolutions)humanized beta-amyloid oligomer mAb (Emergent BioSolutions/University of Manitoba/University of British Columbia)h5E3
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEmergent Biosolutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of ManitobaThe University Of British ColumbiaAptevo Therapeutics Inc
Inactive CompaniesEmergent Biosolutions Inc
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A